Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production (Q41051889)

26 September 2017

title

Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production (English)

1 reference

26 September 2017

1 reference

E Nissinen

1

1 reference

26 September 2017

P Kaheinen

2

1 reference

26 September 2017

K E Penttilä

3

1 reference

26 September 2017

J Kaivola

4

1 reference

26 September 2017

I B Lindén

5

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

European Journal of Pharmacology

26 September 2017

published in

1 reference

26 September 2017

volume

340

1 reference

26 September 2017

issue

2-3

1 reference

26 September 2017

page(s)

287-294

1 reference

Effect of entacapone, a COMT inhibitor, on the pharmacokinetics and metabolism of levodopa after administration of controlled-release levodopa-carbidopa in volunteers

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Control of respiration and ATP synthesis in mammalian mitochondria and cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Application and validation of an ion-exchange high-performance liquid chromatographic method for measuring adenine nucleotides, creatine and creatine phosphate in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose levodopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

The mitochondrial electron transport and oxidative phosphorylation system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Lipid solubility as a factor influencing the activity of uncoupling phenols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Inhibition of soluble catechol-O-methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson's disease patients. Grupo-Centro de Trastornos del Movimiento.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Oxidative damage caused by free radicals produced during catecholamine autoxidation: protective effects of O-methylation and melatonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

In vitro interaction of nonsteroidal anti-inflammatory drugs on oxidative phosphorylation of rat kidney mitochondria: respiration and ATP synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Inhibition of mitochondrial respiration by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Role of glycolytic flux in effect of glucose in decreasing fatty-acid-induced release of lactate dehydrogenase from isolated coronary ligated rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Role of Ca2+ in toxic cell killing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Abnormalities of the electron transport chain in idiopathic Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Mitochondrial complex I deficiency in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Review: The Biochemical Basis of Non-Steroidal Anti-Inflammatory Drug-Induced Damage to the Gastrointestinal Tract: A Review and a Hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901431-3

10.1016/S0014-2999(97)01431-3

7 January 2021

Identifiers

DOI

1 reference

26 September 2017

1 reference